BSQJG - STP HEAVY DUTY BRAKE PARTS CLEANER

  • MSDS: BSQJG
  • Manufacturer: FIRST BRANDS CORP
  • Product Name: STP HEAVY DUTY BRAKE PARTS CLEANER
  • National Stock Number: 6850-00D003194
Product Identification

Product ID:STP HEAVY DUTY BRAKE PARTS CLEANER
MSDS Date:01/09/1990
FSC:6850
NIIN:00D003194
MSDS Number: BSQJG

Responsible Party
FIRST BRANDS CORPORATION
83 WOOSTER HEIGHTS ROAD BUILDING 301
DANBURY, CT 06813-1911
US

Emergency Phone: 800-424-9300 CHEMTREC

Info Phone: 203-731-2300

Preparer: R.L. LEWIS

Cage: DO273

Contractor
PRESTONE PRODUCTS CORP
DANBURY, CT 06810-5109 US

Telephone: 203-731-3686/830-7865

Cage: 0CXZ7

Ingredients

METHYL CHLOROFORM (1,1,1-TRICHLOROEHANE) (SARA III)

CAS: 71-55-6

RTECS: KJ2975000

Fraction By Weight: 60-80%

OSHA PEL 350 PPM

ACGIH TLV: 350 PPM/450STEL;9394

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS


PERCHLOROETHYLENE (TETRACHLOROETHYLENE) (SARA III)

CAS: 127-18-4

RTECS: KX3850000

Fraction By Weight: 20-40%

OSHA PEL 25 PPM

ACGIH TLV: 25 PPM/100STEL,A3;94

EPA Report Quantity: 100 LBS

DOT Report Quantity: 100 LBS

Hazards

Routes of Entry: Inhalation:YES Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE: INHALATION OR INGESTION MAY
CAUSE CENTRAL NERVOUS SYSTEM DEPRESSION. INHALATION MAY ALSO CAUSE
RESPIRATORY TRACT IRRITATION. CONTACT MAY CAUSE SKIN AND EYE
IRRITATION. INGESTION MAY ALSO CAUSE TRANSIENT KIDNEY OR LIVER
DAMAGE: CHRONIC: PROLONGED/REPEATED EXPOSURE MAY CAUSE DERMATITIS.
Explanation of Carcinogenicity:NO INGREDIENT OF A CONCENTRATION OF 0.1%
OR GREATER IS LISTED AS A CARCINOGEN OR SUSPECTED CARCINOGEN.
Effects of Overexposure:INHALED: COUGH, NASAL DISCHARGE, HEADACHE,
DROWSINESS, DIZZINESS, INCOORDINATION, UNCONSCIOUSNESS, RESPIRATORY
FAILURE, DEATH. EYES: REDNESS, PAIN, BLURRED VISION, TEARING. SKIN:
REDNESS, ITCHING, SWE LLING. INGESTED: HEADACHE, NAUSEA,
DROWSINESS, INCOORDINATION, UNCONSCIOUSNESS, RESPIRATORY FAILURE,
DEATH.
Medical Cond Aggravated by Exposure:PRE-EXISTING DERMATITIS, HEART
CONDITIONS, ABNORMAL LUNG FUNCTION, LIVER OR KIDNEY FUNCTION.

First Aid

First Aid:INHALED: REMOVE TO FRESH AIR. GIVE ARTIFICIAL RESPIRATION IF
BREATHING STOPPED, OXYGEN IF BREATHING DIFFICULT. GET MEDICAL
ATTENTION. EYES: FLUSH WITH LOTS OF WATER FOR 15 MINUTES. SKIN:
WASH WITH SOA P AND WATER. IF IRRITATION PERSISTS, SEE DOCTOR.
INGESTED: IF CONSCIOUS, GIVE 2 GLASSES OF MILK OR WATER. INDUCE
VOMITING. GET MEDICAL ATTENTION. SEE SUPPLEMENTAL INSTRUCTIONS FOR
NOTES TO PHYSICIANS.

Fire Fighting

Flash Point Method:PMCC
Flash Point:NONE
Extinguishing Media:WATER FOG, FOAM, ALCOHOL FOAM, CARBON DIOXIDE, AND
DRY CHEMICAL
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
FULL PROTECTIVE GEAR. COOL FIRE EXPOSED CONTAINERS WITH WATER.
Unusual Fire/Explosion Hazard:NONE

Accidental Release

Spill Release Procedures:WEAR APPROPRIATE PERSONAL PROTECTIVE
EQUIPMENT. COLLECT MATERIAL FOR DISPOSAL.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling

Handling and Storage Precautions:USE IN A WELL-VENTILATED AREA. STORE
IN A COOL, DRY PLACE AWAY FROM SOURCES OF IGNITION, OUT OF DIRECT
SUNLIGHT, & AWAY FROM INCOMPATIBLE MATERILAS.
Other Precautions:DO NOT STORE ABOVE 120F. DO NOT BREATH VAPORS. AVOID
EYE AND PROLONGED SKIN CONTACT. CAUTION: CONTENTS UNDER PRESSURE
(90 PSI).

Exposure Controls

Respiratory Protection:NONE NORMALLY REQUIRED. IF ENGINEERING CONTROLS
FAIL OR NON-ROUTINE USE OR EMERGENCY OCCURS; USE NIOSH/MSHA
APPROVED RESPIRATOR WITH ORGANIC VAPOR CARTRIDGE OR SUPPLIED AIR
RESPIRATOR OR SCBA, AS REQU IRED. USE IAW 29 CFR 1910.134.
Ventilation:USE ADEQUATE MECHANICAL VENTILATION OR LOCAL EXHAUST TO
MAINTAIN EXPOSURE BELOW PEL.
Protective Gloves:PVA
Eye Protection:SAFETY GLASSES/CHEMICAL SPLASH GOGGLES
Other Protective Equipment:EYE WASH STATION & SAFETY SHOWER
Work Hygienic Practices:WASH HANDS AFTER USE AND BEFORE EATING,
DRINKING, OR SMOKING. LAUNDER CONTAMINATED CLOTHES BEFORE REUSE.
Supplemental Safety and Health
DOCTOR'S NOTES: PRODUCT MAY SENSITIZE MYOCARDIUM TO EPINEPHRINE; AVOID
THE USE OF EPNIEPHRINE. THERE IS NO SPECIFIC ANTIDOTE. TREATMENT OF
OVEREXPOSURE SHOULD BE DIRECTED AT THE CONTROL OF SYMPTOMS AN D THE
CLINICAL CONDITION.

Chemical Properties

HCC:V2
Boiling Pt:=72.2C, 162.F
Melt/Freeze Pt:=-40.C, -40.F
Vapor Pres:120 MM HG
Vapor Density:1 (AIR=1)
Spec Gravity:1.3 (WATER=1)
Evaporation Rate & Reference:6 (N-BUTYL ACETATE=1)
Solubility in Water:INSOLUBLE
Appearance and Odor:CLEAR LIQUID, ODOR OF CHLORINATED HYDROCARBON
Percent Volatiles by Volume:100

Stability

Stability Indicator/Materials to Avoid:YES
KETONES AND STRONG OXIDIZING AGENTS
Stability Condition to Avoid:SPARKS, HEAT, AND OPEN FLAME. CONTACT WITH
KETONES AND STRONG OXIDIZING AGENTS.
Hazardous Decomposition Products:FUMES OF 1,1,1-TRICHLOROETHANE,
PERCHLORETHANE, CHLORINE.

Disposal

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH LOCAL, STATE AND
FEDERAL RCRA REGULATIONS. EPA WASTE NUMBERS D039, U226, FOO1, FOO2
MAY APPLY.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.